J 2019

Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

ARAB, Anas, Jana RUDÁ, Alžběta MINSTEROVÁ, Eva DRAŽANOVÁ, Nikoletta SZABÓ et. al.

Basic information

Original name

Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease.

Name in Czech

Změny zobrazování kurtózy difúze v metamfetaminem indukovaném myším modelu Parkinsonovy menoci.

Authors

ARAB, Anas (760 Syrian Arab Republic, belonging to the institution), Jana RUDÁ (203 Czech Republic, guarantor, belonging to the institution), Alžběta MINSTEROVÁ (203 Czech Republic, belonging to the institution), Eva DRAŽANOVÁ (203 Czech Republic, belonging to the institution), Nikoletta SZABÓ (348 Hungary, belonging to the institution), Zenon STARČUK (203 Czech Republic), Irena REKTOROVÁ (203 Czech Republic, belonging to the institution) and Amit Suresh KHAIRNAR (356 India, belonging to the institution)

Edition

Neurotoxicity research, New York, Springer, 2019, 1029-8428

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.992

RIV identification code

RIV/00216224:14110/19:00110693

Organization unit

Faculty of Medicine

UT WoS

000494483100008

Keywords in English

Behaviour; Diffusion kurtosis imaging; MRI; Methamphetamine; Mice; Parkinson’s disease; Tract-based spatial statistics

Tags

International impact, Reviewed
Změněno: 8/10/2024 08:29, Ing. Jana Kuchtová

Abstract

V originále

Methamphetamine (METH) abuse is known to increase the risk of Parkinson's disease (PD) due to its dopaminergic neurotoxicity. This is the rationale for the METH model of PD developed by toxic METH dosing (10 mg/kg four times every 2 h) which features robust neurodegeneration and typical motor impairment in mice. In this study, we used diffusion kurtosis imaging to reveal microstructural brain changes caused by METH-induced neurodegeneration. The METH-treated mice and saline-treated controls underwent diffusion kurtosis imaging scanning using the Bruker Avance 9.4 Tesla MRI system at two time-points: 5 days and 1 month to capture both early and late changes induced by METH. At 5 days, we found a decrease in kurtosis in substantia nigra, striatum and sensorimotor cortex, which is likely to indicate loss of DAergic neurons. At 1 month, we found an increase of kurtosis in striatum and sensorimotor cortex and hippocampus, which may reflect certain recovery processes. Furthermore, we performed tract-based spatial statistics analysis in the white matter and at 1 month, we observed increased kurtosis in ventral nucleus of the lateral lemniscus and some of the lateral thalamic nuclei. No changes were present at the early stage. This study confirms the ability of diffusion kurtosis imaging to detect microstructural pathological processes in both grey and white matter in the METH model of PD. The exact mechanisms underlying the kurtosis changes remain to be elucidated but kurtosis seems to be a valuable biomarker for tracking microstructural brain changes in PD and potentially other neurodegenerative disorders.

Links

EF16_013/0001775, research and development project
Name: Modernizace a podpora výzkumných aktivit národní infrastruktury pro biologické a medicínské zobrazování Czech-BioImaging
MUNI/A/1550/2018, interní kód MU
Name: Farmakologický výzkum v oblasti farmakokinetiky, neuropsychofarmakologie a onkologie
Investor: Masaryk University, Category A
ROZV/24/LF/2018, interní kód MU
Name: LF - Příspěvek na IP 2108
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
90062, large research infrastructures
Name: Czech-BioImaging